Trial Condition(s):

Postmenopause, Hormone Replacement Therapy

Study to assess safety of a hormone therapy preparation containing Drospirenone/Estradiol in women with concomitant disease and medication known to potentate the risk of hyperkalemia

Bayer Identifier:

91052

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
230
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design